# Client Presentation Materials
## EV Analysis Platform - PC3 Exosome Validation
### Date: January 20, 2026

---

## üìÅ Folder Contents

### üî¥ START HERE - Main Documents

| # | File | Description |
|---|------|-------------|
| 1 | `BIOVARAM_USER_MANUAL.pdf` | **üìñ User Manual** - Complete step-by-step guide for using the platform |
| 2 | `NTA_AND_NANOFACS_GUIDE.pdf` | **Read First** - Explains what NTA and NanoFACS are and how to interpret the reports |
| 3 | `CLIENT_VALIDATION_REPORT_JAN20_2026.pdf` | **Main Report** - Executive summary with validation results, charts, and conclusions |

---

### üìä NTA Sample Reports (ZetaView Style)
Individual size distribution reports for each PC3 exosome fraction.

| File | Sample | D50 | Status |
|------|--------|-----|--------|
| `PC3_100kDa_F5_report.pdf` | Fraction 5 | 127.5 nm | ‚úÖ Pass |
| `PC3_100kDa_F1_2_report.pdf` | Fraction 1-2 | 147.5 nm | ‚úÖ Pass |
| `PC3_100kDa_F3T6_report.pdf` | Fraction 3-6 | 157.5 nm | ‚úÖ Pass |
| `PC3_100kDa_F7_8_report.pdf` | Fraction 7-8 | 172.5 nm | ‚úÖ Pass |
| `PC3_100kDa_F9T15_report.pdf` | Fraction 9-15 | 162.5 nm | ‚úÖ Pass |

---

### üî¨ FCS Sample Reports (NanoFACS Style)
Flow cytometry scatter plots and statistics for marker analysis.

| File | Sample | Events | Description |
|------|--------|--------|-------------|
| `PC3 EXO1_report.pdf` | Main exosome | 914,326 | Primary EV preparation |
| `Exo+CD 81_report.pdf` | CD81 stained | 475,250 | Exosome marker positive |
| `Exo+CD 81 +ISOTYPE1_report.pdf` | CD81 isotype | 1,187,417 | Negative control |
| `Exo+CD 9_report.pdf` | CD9 stained | 1,190,557 | Exosome marker positive |
| `Exo+CD 9 +ISOTYPE_report.pdf` | CD9 isotype | 1,160,753 | Negative control |

---

## üìã Presentation Order (Recommended)

1. **Introduction** - Use `NTA_AND_NANOFACS_GUIDE.pdf` to explain the techniques
2. **Results Overview** - Show `CLIENT_VALIDATION_REPORT_JAN20_2026.pdf` for executive summary
3. **Detailed NTA** - Walk through individual NTA sample reports if needed
4. **Marker Analysis** - Show FCS reports to demonstrate CD81/CD9 marker expression

---

## ‚úÖ Key Validation Results

| Metric | Target | Achieved | Status |
|--------|--------|----------|--------|
| NTA D50 Error | < 3% | 0.1% - 2.5% | ‚úÖ PASS |
| PDF Extraction Accuracy | > 95% | 97% | ‚úÖ PASS |
| FCS Parsing Success | 100% | 100% (28/28) | ‚úÖ PASS |
| Cross-validation | Match | NTA ‚Üî NanoFACS agree | ‚úÖ PASS |

---

## üìû Contact

For questions about these reports or the EV Analysis Platform, contact your technical team.

---

*Generated by EV Analysis Platform v1.0*
